• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    Anthem Biosciences Limited — Updates, 21-07-2026: Press Release (Revised)

    21-07-2026 | 07:30 pm

    Anthem Biosciences reported Q1FY27 revenue of ₹418.2 Cr, down 22.6% YoY due to delivery timing shifts. EBITDA was ₹175.5 Cr (39.6% margin) and PAT ₹119.9 Cr (27.1% margin). Management expects strong H2FY27 deliveries and sustained industry-leading margins.

    No comments yet. Be the first to comment!

    All announcements from Anthem Biosciences Limited